With the shelf effective, selling stockholders can immediately begin resales. The ~18% share overhang at a sub-$35M market cap with known going-concern and listing problems makes continued selling pressure the most likely path. Monitor for a Form 424B5/424B3 takedown notice (triggering immediate dilution) or an amendment to the shelf. Expect material stock volatility on any volume pickup linked to this overhang.
Price Chart
Executive Summary
The SEC declared effective Milestone Scientific's S-3 shelf registration (File No. 333-296423) on June 9, 2026, covering the resale of 15,925,926 shares held by selling stockholders from the April 2026 private placement. The company will not receive proceeds from resales but may receive up to $2.69M if warrants are fully exercised. The effectiveness removes the final regulatory barrier for selling stockholder resales, creating an immediate overhang of shares equal to ~18% of current outstanding stock in a company with a $34M market cap and going-concern risk.
Key Facts
- Effectiveness declared June 9, 2026 for S-3 shelf (File No. 333-296423) filed June 2, 2026
- Covers up to 15,925,926 shares (7,962,963 initial shares + 7,962,963 warrant shares) held by selling stockholders
- Company received $2.15M gross from the private placement ($1.799M cash + $351K note conversion) and will not receive proceeds from resales
- Full warrant exercise would yield additional $2.6875M to the company
- Overhang represents ~18% of current outstanding shares against $34M market cap
- Issuer has going-concern disclosure, NYSE American listing deficiency, and ~$2.9M annual operating cash burn
Financial Impact
Potential dilution overhang equal to ~18% of outstanding shares; company may receive up to $2.6875M from warrant exercise if all warrants are exercised
Risk Factors
- Immediate resale of shares by selling stockholders could depress stock price
- Full warrant exercise could dilute existing common holders further
- Ongoing NYSE American listing deficiency may lead to delisting
- Cash burn of ~$2.9M/year stresses the balance sheet, potentially forcing additional capital raises
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001935 |
| Document: 9999999995-26-001935-index.html | 9999999995-26-001935 |
| Document: 9999999995-26-001935.txt | 9999999995-26-001935 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 29, 2026 28d ago | EFFECT | $0.4100 $0.3671 | ▲ +10.46% | ▲ +12.41% | $0.3000 (+26.83%) |
Sep 18, 2026 5w ago | S-3/A | $0.3908 $0.4100 | ▲ +4.91% | ▲ +5.93% | $0.3000 (−23.23%) |
Aug 14, 2026 10w ago | Press Release | $0.4951 $0.4808 | ▼ −2.89% | ▼ −1.52% | $0.3000 (−39.41%) |
Jul 31, 2026 12w ago | 8-K | $0.3990 $0.4811 | ▲ +20.58% | ▲ +17.07% | $0.3000 (−24.81%) |
Jul 29, 2026 12w ago | 8-K | $0.3911 $0.4650 | ▲ +18.90% | ▲ +15.27% | $0.3000 (−23.29%) |
Jun 10, 2026 19w ago | EFFECT | $0.3899 $0.3400 | ▲ +12.80% | ▲ +16.23% | $0.3000 (+23.06%) |
Jun 2, 2026 20w ago | S-3 | $0.3900 $0.3900 | · 0.00% | ▼ −3.82% | $0.3000 (+23.08%) |
May 27, 2026 21w ago | Press Release | $0.3900 $0.3900 | · 0.00% | ▼ −1.21% | $0.3000 (−23.08%) |
May 14, 2026 23w ago | Press Release | $0.3400 $0.3900 | ▲ +14.71% | ▲ +15.42% | $0.3000 (−11.76%) |
May 6, 2026 24w ago | 8-K | $0.4700 $0.3500 | ▼ −25.53% | ▼ −27.04% | $0.3000 (−36.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers